HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Agranulocytosis following phenytoin-induced hypersensitivity syndrome.

Abstract
Phenytoin, one of the most common antiepileptic drugs, is a major cause of antiepileptic drug hypersensitivity syndrome (AHS), which is a rare but potentially fatal complication. We herein report a 5-year-old boy who developed unexpected agranulocytosis with fever approximately one week after recovering from the typical symptoms of AHS, characterized by fever, rash, lymphadenopathy, and hepatitis, but lacking eosinophilia or lymphocytosis. High-dose steroid therapy for the former symptoms of AHS, and immunoglobulin, granulocyte colony-stimulating factor, and cefepime for the latter agranulocytosis were successfully performed. This unexpected progression from AHS to agranulocytosis shortly after recovering from the former should be recognized as another risk of AHS, possibly leading to a life-threatening condition.
AuthorsSusumu Ito, Mutsuki Shioda, Kaori Sasaki, Kaoru Imai, Hirokazu Oguni, Makiko Osawa
JournalBrain & development (Brain Dev) Vol. 31 Issue 6 Pg. 449-51 (Jun 2009) ISSN: 1872-7131 [Electronic] Netherlands
PMID18774664 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Anticonvulsants
  • Cephalosporins
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Steroids
  • Granulocyte Colony-Stimulating Factor
  • Phenytoin
  • cefepime
Topics
  • Agranulocytosis (chemically induced, drug therapy, physiopathology)
  • Anti-Bacterial Agents (administration & dosage)
  • Anticonvulsants (adverse effects)
  • Cephalosporins (administration & dosage)
  • Child, Preschool
  • Disease Progression
  • Drug Hypersensitivity (complications, drug therapy, physiopathology)
  • Drug-Induced Liver Injury (drug therapy, physiopathology)
  • Epilepsy (drug therapy)
  • Exanthema (chemically induced)
  • Granulocyte Colony-Stimulating Factor (administration & dosage)
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage)
  • Immunosuppressive Agents (administration & dosage)
  • Lymphatic Diseases (chemically induced, drug therapy, physiopathology)
  • Male
  • Phenytoin (adverse effects)
  • Risk Factors
  • Steroids (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: